Cholestatic Jaundice as a Paraneoplastic Manifestation of Prostate Adenocarcinoma

Clinical Gastroenterology and Hepatology

Volumn 1, Issue 6, 2003, Pages 480-483

  Karakolios, Apostolos ^a,b   Kasapis, Christos ^a   Kallinikidis, Theofilos ^a   Kalpidis, Panagiotis ^a   Grigoriadis, Nikolaos ^a  

^a General District Hospital of Serres   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BICALUTAMIDE; FLUTAMIDE; FOSINOPRIL; INDAPAMIDE; LEUPRORELIN;

AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILE DUCT OBSTRUCTION; BILIRUBIN BLOOD LEVEL; BONE SCINTISCANNING; CANCER HORMONE THERAPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; DIARRHEA; DISEASE COURSE; ECHOGRAPHY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LABORATORY TEST; LIVER METASTASIS; MALE; OBSTRUCTIVE JAUNDICE; PARANEOPLASTIC SYNDROME; PHYSICAL EXAMINATION; PROSTATE ADENOCARCINOMA; PRURITUS; TREATMENT OUTCOME;

EID: 0242694379     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(03)00227-1     Document Type: Article

References (17)

1. Cole A, Mendelblatt D, Aguayo J, Mathew A, Martin E, Vesely DL. Metastatic prostate cancer (with prostate-specific antigen of 9996) presenting as obstructive jaundice. Am J Med Sci 2000;319:118-122.
2. Ben-Ishay D, Slavin S, Levij IS, Eliakim M. Obstructive jaundice associated with carcinoma of the prostate. Isr J Med Sci 1975;11:838-844.
3. Bloch WE, Block NL. Metastatic prostate cancer presenting as obstructive jaundice. Urology 1992;40:456-457.
4. Reddy AN, Grosberg SJ, Wapnick S. Intermittent cholestatic jaundice and nonmetastatic prostatic carcinoma. Arch Intern Med 1977;137:1616-1618.
5. Moris de la Tassa J, Claros Gonzalez I, Garcia-Alcalde Fernandez ML, Antuna Egocheaga A, Arguelles Torano M. Colestasis y carcinoma de prostata. Descripcion de un caso y revision de las colestasis paraneoplasicas. Med Clin (Barc) 1991;96:22-25.
6. Walther MM, Johnson B, Culley D, Shah R, Weber J, Venzon D, Yang JC, Linelian WM, Rosenberg SA. Serum interleukin-6 levels in metastatic renal cell carcinoma before treatment with interleukin-2 correlates with paraneoplastic syndromes but not patient survival. J Urol 1998;159:718-722.
7. Gil H, de Wazieres B, Desmurs H, Fest T, Dupond JL. Stauffer's syndrome disclosing kidney cancer: another cause of inflammatory syndrome with anicteric cholestasis. Rev Med Interne 1995;16:775-777.
8. Epstein JI. Pathology of prostatic neoplasia. In: Walsh PC, Retic AB, Vaughan ED Jr, Wein AJ, eds. Campbell's urology. 8th ed. Philadelphia: Saunders, 2002:3025-3037.
9. Pratt DS, Kaplan MM. Jaundice. In: Braunwald E, Fauci A, Kasper D, Hauser S, Lango D, Jameson JL, eds. Harrison's principles of internal medicine. 15th ed. New York: McGraw-Hill, 2001:255-259.
10. Dourakis SP, Tzemanakis E, Deutsch M, Kafiri G, Hadziyannis SJ. Fulminant hepatic failure as a presenting paraneoplastic manifestation of Hodgkin's disease. Eur J Gastroenterol Hepatol 1999;11:1055-1058.
11. Yalcin S, Kars A, Sokmensuer C, Atahan L. Extrahepatic Hodgkin's disease with intrahepatic cholestasis: report of two cases. Oncology 1999;57:83-85.
12. Jansen PL, van der Lelie H. Intrahepatic cholestasis and biliary cirrhosis associated with extrahepatic Hodgkin's disease. Neth J Med 1994;44:99-102.
13. Dourakis SP, Sinani C, Deutsch M, Dimitriadou E, Hadziyannis SJ. Cholestatic jaundice as a paraneoplastic manifestation of renal cell carcinoma. Eur J Gastroenterol Hepatol 1997;9:311-314.
14. Watterson J, Priest JR. Jaundice as a paraneoplastic phenomenon in a T-cell lymphoma. Gastroenterology 1989;97:1319-1322.
15. Pandey J, Bhowmik KT. Chronic lymphocytic leukaemia presenting as jaundice. Indian J Gastroenterol 1998;17:28.
16. Chang SY, Yu DS, Sherwood ER, Kozlowski JM, Lee C. Inhibitory effects of suramin on a human renal cell carcinoma line, causing nephrogenic hepatic dysfunction. J Urol 1992;147:1147-1150.
17. Blay JY, Rossi JF, Wijdenes J, Menetrier-Caux C, Schemann S, Négrior S, Philip T, Faurot M. Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int J Cancer 1997;72:424-430.